81 research outputs found
Clinical Characteristics And Response Outcomes in Older Multiple Myeloma Patients Who Received Idecabtagene Vicleucel : A Single Center Study
Nilesh Kalariya pictured.https://openworks.mdanderson.org/aprn-week-22/1014/thumbnail.jp
Targeting DNA2 Overcomes Metabolic Reprogramming in 1q21 Multiple Myeloma
View full abstracthttps://openworks.mdanderson.org/leading-edge/1018/thumbnail.jp
Tairona culture artefacts, Museo del Oro, Bogota, Colombia, 1977, [10] [picture] /
Condition: Good.; Title devised by cataloguer based on inscription on reverse.; Part of Wolfgang Sievers photographic archive.; Sievers number: EK-4560-add84 (devised number).; Inscriptions: "Tairona-24265-24665".; Also available in an electronic version via the Internet at: http://nla.gov.au/nla.pic-vn4195867
Recommended from our members
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions
Epidemiologic studies provide an insight into the etiology of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia, which indicates that repetitive immune stimulation and genetic factors play an important role. Here, the current understanding on the causes of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia are reviewed. Recent studies of the literature are discussed, and future population-based studies are proposed to further elucidate the molecular mechanisms that underlie these associations. Finally, the clinical implications of these data are outlined, and perspectives on clinical follow-up and counseling are provided
Gefitinib and Erlotinib in Metastatic Non‐Small Cell Lung Cancer: A Meta‐Analysis of Toxicity and Efficacy of Randomized Clinical Trials
Recommended from our members
Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström's macroglobulinemia
Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials
- …